A Fatal Case of Rhizopus azygosporus Pneumonia Following COVID-19.

Anubhav KanwarAlex JordanScott OlewilerKurt WehbergMichael CortesBrendan R Jackson

Published in: Journal of fungi (Basel, Switzerland) (2021)

We report a fatal case of Rhizopus azygosporus pneumonia in a 56-year-old man hospitalized for COVID-19 who had received methylprednisolone and tocilizumab. Although COVID-associated pulmonary aspergillosis has been widely documented, mucormycosis has been rarely reported. In this patient, receipt of two commonly used immunosuppressants likely contributed to mucormycosis risk, suggesting the need for vigilance in hospitalized patients with COVID-19.

Keyphrases

coronavirus disease
sars cov
rheumatoid arthritis
respiratory syndrome coronavirus
high dose
low dose
juvenile idiopathic arthritis
intensive care unit
disease activity
mechanical ventilation